Skip to main content

Table 2 Quantification metrics for all patients

From: Vascular measurements correlate with estrogen receptor status

De-ID patient # Er + or ER- Percent ER + cells Stain intensity Allred score Histological score # of vessels per unit area (um2) Maximum vessels area (um2) Mean vessels area (um2) Mean vessels perimeter (um) Mean lumen area (um2) Necrotic area per tumor area
Patient 1 - 0 0 0 0 2.12E-04 1301 197.3 91.5 47.5 23.1
Patient 2 - 0 0 0 0 7.97E-05 153 63.1 41.4 7.7 69.3
Patient 3 - 0 0 0 0 3.67-04 2124 224.4 107.4 21.2 <.5
Patient 4 - 0 0 0 0 5.19E-05 329 102.8 58.2 8.2 16.2
Patient 5 - 0 0 0 0 1.14E-03 12195 287.9 141.5 34.4 22.4
Patient 6 - 0 0 0 0 1.56E-03 8609 178.0 82.9 28.9 14.9
Patient 7 + 90 1+ to 3+ 6 150 6.19E-04 13082 482.8 195.7 72.3 33.7
Patient 8 + 95 1+ to 3+ 7 155 4.35E-04 4560 307.4 142.1 44.6 1.1
Patient 9 + 95 1+ to 3+ 7 165 8.38E-04 12672 282.1 122.8 40.4 <.5
Patient 10 + 90 2+ 7+ 170 7.23E-04 14879 347.7 153.3 34.8 22.1
Patient 11 + 100 1+ to 3+ 8 200 4.79E-05 1784 368.6 138.2 33.3 4.7
Patient 12 + 95 1+ to 3+ 7 240 5.39E-04 6274 267.6 107.4 61.5 <.5
Patient 13 + 100 2 + 0 to 3+ 8 260 5.59E-05 7927 671.4 258.4 16.5 5.2
Patient 14 + 90 3+ 8 270 9.18E-04 19704 465.8 191.7 23.2 2.5
Patient 15 + 90 3+ 8 270 7.66E-04 16094 341.9 130.9 21.7 <.5
Patient 16 + 100 2+ to 3+ 8 270 4.67E-04 1712 178.8 98.7 40.4 1.6
Patient 17 + 100 2+ to 3+ 8 270 7.27E-04 19485 436.3 174.1 29.3 <.5
Patient 18 + 100 2+ to 3+ 8 280 8.26E-04 4379 221.2 110.9 65.8 <.5
Patient 19 + 100 3+ 8 300 2.35E-04 1619 172.4 80.6 30.9 3.9
Patient 20 + 100 3+ 8 300 8.78E-05 3673 312.2 152.3 17.6 <.5
Patient 21 + 100 3+ 8 300 5.03E-04 8258 271.8 115.4 47.7 <.5
Patient 22 + 100 3+ 8 300 4.87E-04 17390 373.7 158.7 52.3 <.5
Patient 23 + 100 3+ 8 300 7.74E-04 14857 512.3 237.2 58.8 <.5
Patient 24 + 100 3+ 8 300 7.03E-04 11188 438.0 156.7 40.9 <.5
Neg control NA NA NA NA NA 1.72E-04 2207 116.1 59.3 6.3 NA
Pos control NA NA NA NA NA 9.78E-04 11836 345.8 156.3 22.4 NA
  1. Summary of all quantification metrics for all patients.